Talking stocks, trading, and investing in general

[RockinIt]

Do any of you guys use a forum like this but for stocks?

[locutus49]

Seeking Alpha

Originally Posted by RockinIt

Do any of you guys use a forum like this but for stocks?

[Jbranda]

Originally Posted by locutus49

Seeking Alpha

Some of the guys on there are biased and paid to write what they write.

[BNA/LION]

Originally Posted by BNALION

Looking for Big things from ASPX in early December....Giddy Up!

HOME RUN!

DJ Auspex Shares Rise After Company Reports Favorable Drug Results -- Update

Dec 16, 2014 18:37:00 (ET)


By Josh Beckerman


Auspex Pharmaceuticals Inc. reported favorable results from a Phase 3 trial evaluating its SD-809 drug as a treatment for chorea related to Huntington's disease.

In late trading, Auspex shares rose 68.6% to $42.30. The company went public in February at $12. Huntington's disease is a brain disorder that causes uncontrolled movement and loss of brain function. Auspex said about 90% of patients with Huntington's disease will develop chorea, which is characterized by involuntary, excessive movements that interfere with motor functions.

The study met its primary efficacy endpoint and showed a favorable safety and tolerability profile, the biotech company said. "Significant improvements in both patient and clinical global impressions of change and quality of life were observed," the company said.

"We are committed to rapidly advancing SD-809 along its regulatory pathway" and submitting a New Drug Application by mid-2015, Auspex said.

The Food and Drug Administration granted orphan drug designation for the treatment in November.

Auspex also plans to explore use of SD-809 in other movement disorders including tardive dyskinesia and Tourette syndrome, and expects to report trial data for treatment of those conditions in mid-2015.

There is no cure for Huntington's disease. Other companies developing treatments including Annexion Bioscience, which just raised $34 million in venture capital. Teva Pharmaceutical Industries Ltd. and partner Active Biotech AB are testing another possible treatment.

-Brian Gormley contributed to this article.


Write to Josh Beckerman at josh.beckerman@wsj.com


Subscribe to WSJ: http://online.wsj.com?mod=djnwires


(END) Dow Jones Newswires

December 16, 2014 18:37 ET (23:37 GMT)
Copyright (c) 2014 Dow Jones & Company, Inc.

[Jbranda]

Originally Posted by BNALION

HOME RUN!

DJ Auspex Shares Rise After Company Reports Favorable Drug Results -- Update

Dec 16, 2014 18:37:00 (ET)


By Josh Beckerman


Auspex Pharmaceuticals Inc. reported favorable results from a Phase 3 trial evaluating its SD-809 drug as a treatment for chorea related to Huntington's disease.

In late trading, Auspex shares rose 68.6% to $42.30. The company went public in February at $12. Huntington's disease is a brain disorder that causes uncontrolled movement and loss of brain function. Auspex said about 90% of patients with Huntington's disease will develop chorea, which is characterized by involuntary, excessive movements that interfere with motor functions.

The study met its primary efficacy endpoint and showed a favorable safety and tolerability profile, the biotech company said. "Significant improvements in both patient and clinical global impressions of change and quality of life were observed," the company said.

"We are committed to rapidly advancing SD-809 along its regulatory pathway" and submitting a New Drug Application by mid-2015, Auspex said.

The Food and Drug Administration granted orphan drug designation for the treatment in November.

Auspex also plans to explore use of SD-809 in other movement disorders including tardive dyskinesia and Tourette syndrome, and expects to report trial data for treatment of those conditions in mid-2015.

There is no cure for Huntington's disease. Other companies developing treatments including Annexion Bioscience, which just raised $34 million in venture capital. Teva Pharmaceutical Industries Ltd. and partner Active Biotech AB are testing another possible treatment.

-Brian Gormley contributed to this article.


Write to Josh Beckerman at josh.beckerman@wsj.com


Subscribe to WSJ: http://online.wsj.com?mod=djnwires


(END) Dow Jones Newswires

December 16, 2014 18:37 ET (23:37 GMT)
Copyright (c) 2014 Dow Jones & Company, Inc.

Good call..think it has ny more room?

[BNA/LION]

Jbranda Thanks for the kind words! I do think in the long term there is room for more growth. I am planning on buying on dips as there will likely be some profit taking after the beginning of the year. I have accumulated a lot of shares and have taken profits several times now. The "technology" for drug delivery this company owns is a game changer and can be applied to lots of other drugs. If ASPX doesn't develop others drugs one of the big pharma companies will buy them and do so.

http://seekingalpha.com/article/2764...=22427791&dr=1

[yjfang]

My pick for 2015. FireEye (Nasdaq: FEYE). The absolute leader in advanced cyber attacks and remediation. I am sure you guys have all heard about the Sony hack by now, FireEye was hired by them (after the fact) to clean up the mess.

[yjfang]

Absolutely. Be very careful with Seeking Alpha. Lots of paid shills.

Originally Posted by Jbranda

Some of the guys on there are biased and paid to write what they write.

[tnt]

I probably exit all stocks before year end, and holding my physical golds.

Oil could hit to the low 30s and stays 'til first quarter of 2015.

[RockinIt]

Thought I would revive this thread for 2015, so anyone have 2015 outlooks, mover and shakers or market pull backs?

[M777]

Got in on gpro earlier at close to LOD.

[azguy]

The 30 year treasury traded at down to a yield of 2.47% today

People with mortgages around 4% may get a good chance at refinancing lower. who would have thought....

S&P 500 down .5% today and I have a good screen going

20150115_131139_resized.jpg

[M777]

Took a %60 hit on WTSL today. Luckily it wasn't a huge sum of money, made the mistake of gambling on a failing company. Lesson learned and will continue to hold all my current earners.

[RockinIt]

Originally Posted by M777

Took a %60 hit on WTSL today. Luckily it wasn't a huge sum of money, made the mistake of gambling on a failing company. Lesson learned and will continue to hold all my current earners.

So true. Never catch a falling knife.

[otisc]

Any fans here of The Fly? (IBankCoin.com). I kinda started tuning out a year ago when too much hype was being given to their paid services... but I still find this guy's daily blog and commentary on market mood to be hilarious.

[tnt]

Originally Posted by M777

Took a %60 hit on WTSL today. Luckily it wasn't a huge sum of money, made the mistake of gambling on a failing company. Lesson learned and will continue to hold all my current earners.

The good one will be INTC. I am eyed on this.

BRCD is dared to take the risk. $18- $21ish are not far off (I have it since the $5, and plan to stay until $23).

Get some gold for 2015.

[azguy]

all in baby

20150122_124552_resized.jpg

[teqp]

Originally Posted by azguy

all in baby

Attachment 578948

You like NLY over CMO?

[azguy]

Originally Posted by teqp

You like NLY over CMO?

Not really, they are both sort of the same as they own, manage and finance a portfolio of real estate related investments, including mortgage pass-throughs...

But I don't like the leverage CMO uses and NLY trades 6 million shares a day and CMO trade 800,000 shares a day.

[teqp]

Originally Posted by azguy

Not really, they are both sort of the same as they own, manage and finance a portfolio of real estate related investments, including mortgage pass-throughs...

But I don't like the leverage CMO uses and NLY trades 6 million shares a day and CMO trade 800,000 shares a day.

Thanks for the response. I know CMO is a tenth the size of NLY, but I play with CMO.

[yjfang]

Go with REM if you like a mREITs ETF.

[M777]

Had a excellent run on rxmd today. I'm holding, this has long term potential in my opinion.

[azguy]

RXMD

[BNA/LION]

Originally Posted by yjfang

My pick for 2015. FireEye (Nasdaq: FEYE). The absolute leader in advanced cyber attacks and remediation. I am sure you guys have all heard about the Sony hack by now, FireEye was hired by them (after the fact) to clean up the mess.

Nice move for FEYE Today! On my radar... $34.93 +$1.39 +4.14%

Added more Auspex Pharmaceuticals, Inc. (ASPX) early this week @ $52 when it was off 12% and it is up to $58.46 at close today! Accumulating this stock on the dips! Do your research on the company and place your bets...

Started accumulating positions of Kinder Morgan, Inc. (KMI) @ $41.37... The company is poised for some nice gains. IMHO

[azguy]

Love KMI, a must own

Been buying an ETF symbol "HACK" cyber security play

[BNA/LION]

I'll check out HACK...

ASPX is a Must Own too!

Nice Day! Analyst say $65 target I agree w/ it+
Auspex Pharmaceuticals, Inc. (ASPX)
$60.50 --- Up $2.04 or (3.49%) 3:59PM EST
- Nasdaq Real Time Price

[azguy]

also slowly been buying SWKS and bought lots of Twitter in last 45 days in mid to high 30's

[yjfang]

Thank you! Short Term target on FEYE is $42. Possible that it gets into the $50-60's later this year. Earnings on 2/11 after close.

Originally Posted by BNALION

Nice move for FEYE Today! On my radar... $34.93 +$1.39 +4.14%

Added more Auspex Pharmaceuticals, Inc. (ASPX) early this week @ $52 when it was off 12% and it is up to $58.46 at close today! Accumulating this stock on the dips! Do your research on the company and place your bets...

Started accumulating positions of Kinder Morgan, Inc. (KMI) @ $41.37... The company is poised for some nice gains. IMHO

[yjfang]

Added HACK ETF and HAL today for clients accounts. How much lower can oil go?

[SMD]

Originally Posted by yjfang

Added HACK ETF and HAL today for clients accounts. How much lower can oil go?

People have lost a lot of money asking that same question about interest rates.